To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334

Clinical trial NCT00513279 · COMPLETED

Trial details

NCT number: NCT00513279
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Substance Dependence

Start date: 2007-06-28
Primary completion: 2007-10-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.